Kura Oncology, Inc.
KURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422143
In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 3 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.
Members of Congress who traded KURA
Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.
- Trades
- 1
- Filings
- 1
- Members
- 1
- Buys / sells
- 1 / 0
- Estimated volume
- $8.00K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| Chris JacobsRepublican · House · NY | 1 | 1 / 0 | $8.00K | Dec 12, 2022 | Jan 20, 2023 |
Trades
Every reported trade in Kura Oncology, Inc., newest filings first.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.